Hansen Gwenn bought NRIX

February 3, 2026 · Form 4 insider transaction

Hansen Gwenn bought 31,333 shares of Nurix Therapeutics, Inc. at $0.84 per share, a transaction worth $26.3K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.